Efficacy of intradermal methylene blue injection on postoperative Pain relief in haemorrhoidectomy - a randomized control study

Efficacy of intradermal methylene blue infiltration on postoperative analgesia in haemorrhoidectomy - a randomized control study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102668

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K642- Third degree hemorrhoids Health Condition 2: K643- Fourth degree hemorrhoids

Interventions

Intervention1: Methylene Blue with Bupivacaine: Intradermal Methylene Blue with Bupivacaine infiltration in perianal skin post haemorrhoidectomy Control Intervention1: Bupivacine: Intradermal Bupivaca

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing haemorrhoidectomy in KIMS, Deparment of General Surgery

Exclusion criteria

Exclusion criteria: - Pregnant and Breast feeding female - Allergic to Methlene Blue - Patient having any other perianal condition - Patient not giving consent to be a part of the study

Design outcomes

Primary

Measure	Time frame
Measurement of Visual Analogue Score on DAYS 1-3Timepoint: Day 1 and Day 3	—

Secondary

Measure	Time frame
Comparision of decrease in requirement of postoperative analgesics between the two groupsTimepoint: Day 1 & Day 3	—

Countries

India

Contacts

Public ContactRishi Middha

Kalinga Institute of Medical Sciences

rishimiddha@gmail.com8826423431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026